OPR 003
Alternative Names: Anti-IL-6 mAb (OP-R003-1, 1339) - Vaccinex; Azintrel; mAb 1339; OP-R003; VX 30Latest Information Update: 08 Oct 2015
Price :
$50 *
At a glance
- Originator Vaccinex
- Developer EUSA Pharma; Vaccinex
- Class Monoclonal antibodies
- Mechanism of Action Interleukin 6 inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Haematological malignancies; Rheumatoid arthritis
Most Recent Events
- 08 Oct 2015 Discontinued - Phase-I for Haematological malignancies in USA (Parenteral)
- 08 Oct 2015 Discontinued - Phase-I for Rheumatoid arthritis in USA (Parenteral)
- 12 Jun 2012 EUSA Pharma has been acquired by Jazz Pharmaceuticals plc